Employment Scams – what to look out for, and steps your company can take to fight back
It’s not just the application process that attracts bad actors as highlighted in previous article, “The Recruiter & The Thief” not everyone who applies is interested in the role, some are interested in stealing IP or strategic insights. Employment...
Interview Misadventures and Strange Candidate Stories
Job interviews can be intensely nerve-wracking experiences. With a potential job offer on the line and nerves running high, it can be difficult for candidates to toe the line between professional and memorable… and occasionally, a candidate takes their desire to be...
Issue 3 BioHire RoundUp
Glassdoor’s Decline: Why Going Back to Basics is (and has always been) Key for Genuine Company Insights Glassdoor was once the go-to for semi-authentic company reviews, but since its acquisition by Recruit Holdings Co., Ltd., it seems the site is being...Journal Articles
-
Stay updated with the latest news and trends shaping the biotech recruiting world.
Categories: Issue 5: Q1 2025
-
LinkedIn Overload: Recruiters Live on It, But When Is It Too Much?
Are you a LinkedIn evangelist or do you dread logging in and avoiding the “Linkedin Lunatics?” The platform has changed significantly in recent years, but it’s still vital to successfully finding top talent. Using the right tools and strategies can refocus your recruiting efforts and sharpen them to better fit the new LinkedIn landscape.
Categories: Issue 5: Q1 2025
-
Third-Party Recruitment or In-House Teams: When to Choose One Over the Other
When looking for that bespoke candidate, a partnership between in-house HR and a third-party search firm yields the best results.
Categories: Issue 5: Q1 2025
-
Whether you work from home or go into an office, optimize your desk space to maximize comfort and productivity with these tips.
Categories: Issue 5: Q1 2025
-
Workplace Awards: How Valuable Are They In Attracting Candidates, Really?
Winning workplace awards certainly won’t hurt, but there’s much more to the story.
Categories: Issue 5: Q1 2025
